Ceftobiprole - Injectable Anti-MRSA Cephalosporin Antibiotic
Key Data:
Drug (Brand / Generic)
Zeftera / Zevtera/ ceftobiprole medocaril
Company / Licensee
Basilea Pharmaceutica AG and Cilag AG International (a J &J company)
Therapy Class
β-lactam (cephalosporin)
Product Description
Antibiotic
Current Indication
Treatment of complicated skin and soft tissue infections, complicated skin and skin structure infections, diabetic foot infections, nosocomial pneumonia
Market Sector
Anti-infectives
Development Status
Awaiting final marketing authorisation in US and Europe; approved in Canada, Ukraine and Switzerland
